# Galaxy Capital

> Galaxy Capital is a VC fund in Suzhou backing E-Commerce and Software. See 33 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Suzhou, China
- Total investments: 33
- Last investment: Mar 2026
- Lead investor: 39%
- Last updated: Aug 2026

Galaxy Capital is an Investment firm based in China.

## Contacts

5 contacts available for Galaxy Capital. Shizune tracks 1 team members at Galaxy Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/galaxy-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.4M–$4.3M |
| Series A | $1.4M–$31M |
| Series B | $15M–$145M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| E-Commerce | 6 | 18% |
| Software | 4 | 12% |
| Automotive | 3 | 9% |
| Electronics | 3 | 9% |
| Manufacturing | 3 | 9% |

50 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 11 | 33% |
| Seed | 7 | 21% |
| Series B | 5 | 15% |
| Angel | 4 | 12% |
| Series C | 1 | 3% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 24 | 73% |
| United States | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Huigang Rao | Chief Executive Officer & General Manager | 1 | https://shizune.co/investors/profile/huigang-rao |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GigaAI | Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space. | $145.1M | Series B | Mar 05, 2026 |  |
| Sinsegye | Sinsegye operates as a product-driven enterprise company. Sinsegye is an industrial control supercomputing infrastructure supplier. |  | Seed | Jul 11, 2023 |  |
| Weiyan Medical | Micro Rock Medical is a biopharma and medical firm that focuses on precise molecular diagnosis for infections. |  | Series B | Apr 03, 2023 |  |
| Sinsegye | Sinsegye operates as a product-driven enterprise company. Sinsegye is an industrial control supercomputing infrastructure supplier. |  | Seed | Dec 29, 2022 |  |
| Sinsegye | Sinsegye operates as a product-driven enterprise company. Sinsegye is an industrial control supercomputing infrastructure supplier. |  | Seed | Oct 19, 2022 |  |
| Linli New Energy | Linli New Energy is a smart hardware company that develops and manufactures precursors of lithium iron phosphate cathode materials. It was founded in 2016 in Wuhan, Hubei, China. |  | Series B | Sep 29, 2022 |  |
| Sinsegye | Sinsegye operates as a product-driven enterprise company. Sinsegye is an industrial control supercomputing infrastructure supplier. |  | Seed | Sep 07, 2022 |  |
| MaxSense Technology | MaxSense Technology is an autonomous driving and industrial operation optimization developer company. |  | Series A | Aug 17, 2022 |  |
| Hua Kong TsingJiao | Hua Kong TsingJiao is an IT company that focuses on the research, development, and construction of large-scale technology based on modern cryptography and game theory. Its computing platform implements solutions that support general computing types and is compatible with NumPy and Pytorch and other function libraries, which greatly reduces thelearning curve for users to use ciphertext calculations.The company was founded in 2018 and is based in Haidian District, Beijing, China. | $29.6M | Series B | Jul 14, 2022 |  |
| TenNor Therapeutics | TenNor Therapeutics is a clinical stage, product development company with a sharp focus on unmet medical needs in the area of infectious diseases. The company possesses a dual-acting drug discovery platform with several innovative products in various stages of preclinical and clinical development. The company is developing new drugs for thetreatment of Helicobacter pylori infections, prosthetic joint infections, multidrug-resistant Gram-negative infections and some other common and serious infectious diseases. | $41.6M | Series D | Mar 30, 2022 |  |

10 of 33 investments shown.

## Co-investors
- [Zhuoyuan Capital](https://shizune.co/investors/profile/zhuoyuan-capital) — VC Fund, 4 deals together
- [Legend Capital](https://shizune.co/investors/profile/legend-capital) — VC Fund, 3 deals together
- [Qianhai Fund of Funds](https://shizune.co/investors/profile/qianhai-fund-of-funds) — VC Fund, 3 deals together
- [CASVC](https://shizune.co/investors/profile/casvc) — VC Fund, 2 deals together
- [Cowin Capital](https://shizune.co/investors/profile/cowin-capital) — VC Fund, 2 deals together
- [Eastern Bell Capital](https://shizune.co/investors/profile/eastern-bell-venture-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [HOWZAT Partners](https://shizune.co/investors/profile/howzat-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Marketplace Investors in China](https://shizune.co/investors/marketplace-investors-china)
- [Consumer Investors in Asia](https://shizune.co/investors/consumer-investors-asia)
- [Consumer VC Funds in Asia](https://shizune.co/investors/consumer-vc-funds-asia)
- [Transportation VC Funds in China](https://shizune.co/investors/transportation-vc-funds-china)
- [Automotive Investors in Asia](https://shizune.co/investors/automotive-investors-asia)
- [Automotive VC Funds in Asia](https://shizune.co/investors/automotive-vc-funds-asia)

## FAQ

### What does Galaxy Capital invest in?

Galaxy Capital invests primarily in E-Commerce, Software and Automotive startups, most often at Series A and Seed stage. Most of the 33 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Galaxy Capital's check size?

Galaxy Capital typically joins rounds of $1.4M–$4.3M at Seed, $1.4M–$31M at Series A and $15M–$145M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Galaxy Capital participates in.

### How do I contact Galaxy Capital?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Galaxy Capital?

The team at Galaxy Capital includes Huigang Rao (Chief Executive Officer & General Manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co